Paper - WANFANG MED ONLINE

You Position: Home > Paper

Application of 123/131I-MIBG in the diagnosis and treatment of pediatric neuroblastoma

( views:235, downloads:145 )

Author:: No author available

Journal Title:: Chinese Journal of Nuclear Medicine and Molecular Imaging

Issue:: 3

DOI:: 10.3760/cma.j.issn.2095-2848.2017.03.013

Key Word:: 神经母细胞瘤;碘放射性同位素;3-碘苄胍;发展趋势;Neuroblastoma;Iodine radioisotopes;3-Iodobenzylguanidine;Trends

Abstract： As a type of neuroendocrine tumors,neuroblastoma (NB) is the most common extra-cranial solid tumor of childhood.123/131I-MIBG scintigraphy is a standard imaging modality in staging and evaluating therapeutic effect of pediatric NB with high accuracy.131I-MIBG treatment is effective for children with high-risk and relapsed/refractory NB.Combined with chemotherapy,stem cell transplantation,131I-MIBG treatment shows efficacy in decreasing the relapse of pediatric NB.This review summarizes the application of MIBG scintigraphy and 131I-MIBG treatment for pediatric NB.

Reference

[1]朱广文,张延军,解静慧,等.131I-MIBG显像发现腹主动脉旁副神经节瘤一例[J].2004,(3).
[2]廉红云,周春菊,马晓莉,等.生长抑素受体在神经母细胞瘤中的表达及其临床意义[J].2012,(5).
[3]陈燕飞,王天有.神经母细胞瘤的治疗新进展[J].2014,(15).
[4]陈黎波,李方,景红丽,等.99Tcm-HTOC和131I-MIBG显像诊断嗜铬细胞瘤的比较[J].2006,(1).
[5]Wilson,J.S.,Gains,J.E.,Moroz,V.,etc.A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma[J].2014,50(4).
[6]Panigrahy,A.,Weiss,B.,Jackson,H.,etc.Dose escalation study of no-carrier-added 131I- metaiodobenzylguanidine for relapsed or refractory neuroblastoma: New approaches to neuroblastoma therapy consortium trial[J].2012,53(7).
[7]Matthay KK,Hattner RS,Price D,etc.Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.[J].1998,16(1).
[8]Yanik, G. A.,Villablanca, J. G.,Maris, J. M.,etc.131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study[J].2015,21(4).
[9]Matthay,K.K.,Hawkins,R.A.,Wong,T.,etc.Acute changes in blood pressure in patients with neuroblastoma treated with 131I-metaiodobenzylguanidine (MIBG)[J].2013,60(9).
[10]P.A. Voǔte,A.J. van der Kleij,J. De Kraker,etc.Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV[J].1995,31(4).
[11]Hatem, Hammami,Latifa, Hassine,Aida, Mhiri,etc.[Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].[J].2007,85(5).
[12]Hawkins R,Huberty J,Glidden DV,etc.Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.[J].2004,22(12).
[13]M.J. Gelfand,M.G. Stabin.Dosimetry of pediatric nuclear medicine procedures[J].1998,42(2).
[14]Matthay KK,Tan JC,Villablanca JG,etc.Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.[J].2006,24(3).
[15]Thomas Klingebiel,Frank Berthold,Jörn Treuner,etc.Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: Results of the German neuroblastoma trial[J].1991,19(2).
[16]Menda Y,Pashankar FD,O'Dorisio MS.MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.[J].2005,46(Suppl.1).
[17]Steven G, DuBois,Susan, Groshen,Julie R, Park,etc.Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.[J].2015,21.
[18]Pierre, Olivier,Paula, Colarinha,Jure, Fettich,etc.Guidelines for radioiodinated MIBG scintigraphy in children.[J].2003,30(5).
[19]Hawkins,R.,Mosse,Y.P.,Maris,J.M.,etc.Phase I study of vincristine, irinotecan, and 131I- metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: A new approaches to neuroblastoma therapy trial[J].2012,18(9).
[20]J. De Kraker,C.A. Hoefnagel,H. Caron,etc.First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma[J].1995,31(4).
[21]Keri A, Streby,Nilay, Shah,Mark A, Ranalli,etc.Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy.[J].2015,62(1).
[22]F, Bonnin,J, Lumbroso,F, Tenenbaum,etc.Refining interpretation of MIBG scans in children.[J].1994,35(5).
[23]Weiss B,Vora A,Huberty J,etc.Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma.[J].2003,25(7).
[24]M.N. Gaze,T.E. Wheldon,J.A. O'Donoghue,etc.Multi-modality megatherapy with [131I]metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma[J].1995,31(2).
[25]Hanneke M. van Santen,Jan de Kraker,Berthe L. F. van Eck,etc.Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma[J].2003,98(2).
[26]朱瑞森,马寄晓,朱君.131I-MIBG治疗58例恶性嗜铬细胞瘤的临床疗效与副反应[J].1999,(1).
[27]Radojewski, Piotr,Dumont, Rebecca,Marincek, Nicolas,etc.Towards tailored radiopeptide therapy[J].2015,42(8).
[28]Waldman,D.,Ash,S.,Bar-Deroma,R.,etc.Targeted therapy with low doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma[J].2013,15(1).
[29]Soni,S.,Pai,V.,Gross,T.G.,etc.Busulfan and melphalan as consolidation therapy with autologous peripheral blood stem cell transplantation following Children's Oncology Group (COG) induction platform for high-risk neuroblastoma: Early results from a single institution[J].2014,18(2).
[30]Brans B,Chiti A,Lassmann M,etc.EANM procedure guidelines for (131)I-meta-iodobenzylguanidine ((131)I-mIBG) therapy.[J].2008,35(5).